Last month, Murali Neelakantan joined Glenmark Pharmaceuticals as its president and global general counsel. Neelakantan leads the legal and compliance functions for the organization globally.
You must be a
subscribersubscribersubscribersubscriber
to read this content, please
subscribesubscribesubscribesubscribe
today.
For group subscribers, please click here to access.
Interested in group subscription? Please contact us.